• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cytogenetics or MRD in B-cell ALL. Do both reign supreme?

作者信息

Ofran Yishai, Rowe Jacob M

机构信息

Department of Hematology and Bone Marrow Transplantation, Shaare Zedek Medical Center, Faculty of medicine, Hebrew University, Jerusalem, Israel.

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.

出版信息

Leukemia. 2022 May;36(5):1201-1202. doi: 10.1038/s41375-022-01575-4. Epub 2022 Apr 22.

DOI:10.1038/s41375-022-01575-4
PMID:35459874
Abstract
摘要

相似文献

1
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?B细胞急性淋巴细胞白血病中的细胞遗传学或微小残留病。二者都占据主导地位吗？
Leukemia. 2022 May;36(5):1201-1202. doi: 10.1038/s41375-022-01575-4. Epub 2022 Apr 22.
2
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.根据ALL-MB 2008方案治疗的非高危急性淋巴细胞白血病儿童中，考虑细胞遗传学因素的流式细胞术微小残留病检测
Cancer Med. 2024 Apr;13(8):e7172. doi: 10.1002/cam4.7172.
3
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.移植后反应和微小残留病对高危细胞遗传学骨髓瘤生存的影响
Biol Blood Marrow Transplant. 2017 Apr;23(4):598-605. doi: 10.1016/j.bbmt.2017.01.076. Epub 2017 Jan 20.
4
FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.基于 FxCycle™ 的倍性与 B 细胞急性淋巴细胞白血病的细胞遗传学倍性相关，并且能够检测非整倍体微小残留病灶克隆。
Cytometry B Clin Cytom. 2019 Sep;96(5):359-367. doi: 10.1002/cyto.b.21765. Epub 2019 Feb 4.
5
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia.通过流式细胞术评估微小残留病是急性髓系白血病治疗决策中细胞遗传学的一种补充工具。
Leuk Res. 2016 Jan;40:1-9. doi: 10.1016/j.leukres.2015.10.002. Epub 2015 Oct 22.
6
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia.在异基因造血干细胞移植前，通过流式细胞术或细胞遗传学检测到的微小残留病与急性髓系白血病的不良预后相关。
Blood Cancer J. 2017 Nov 27;7(12):634. doi: 10.1038/s41408-017-0007-x.
7
Minimal residual disease is an independent predictor for 10-year survival in CLL.微小残留病是 CLL 患者 10 年生存的独立预测因子。
Blood. 2016 Dec 15;128(24):2770-2773. doi: 10.1182/blood-2016-05-714162. Epub 2016 Oct 3.
8
A Single Institution's Experience with Cytogenetic and MRD Outcomes in Pediatric Acute Lymphoblastic Leukemia.一家机构在儿童急性淋巴细胞白血病细胞遗传学和微小残留病结果方面的经验。
J Coll Physicians Surg Pak. 2019 Jun;29(6):549-552. doi: 10.29271/jcpsp.2019.06.549.
9
Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia.埃及儿童B细胞急性淋巴细胞白血病细胞遗传学亚组的免疫表型特征
Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S19-S24.e1. doi: 10.1016/j.clml.2016.02.032.
10
Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis.多参数流式细胞术检测微小残留病阴性可能改善伴有高危细胞遗传学的 MM 患者的不良预后：一项回顾性单中心分析。
Ann Hematol. 2019 May;98(5):1185-1195. doi: 10.1007/s00277-019-03609-x. Epub 2019 Feb 5.

引用本文的文献

1
A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia.CDKN 缺失在急性淋巴细胞白血病中的预后意义的荟萃分析。
Ann Med. 2024 Dec;56(1):2427365. doi: 10.1080/07853890.2024.2427365. Epub 2024 Nov 18.
2
Measurable residual disease in haematological and solid cancers.血液系统和实体瘤中的可测量残留病
Leukemia. 2024 Aug;38(8):1647-1648. doi: 10.1038/s41375-024-02295-7. Epub 2024 Jun 27.

本文引用的文献

1
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.分子分类可改善成人 BCR-ABL1 阴性 B-ALL 的风险评估。
Blood. 2021 Sep 16;138(11):948-958. doi: 10.1182/blood.2020010144.
2
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.PAX5 驱动的 B 系前体细胞急性淋巴细胞白血病亚型。
Nat Genet. 2019 Feb;51(2):296-307. doi: 10.1038/s41588-018-0315-5. Epub 2019 Jan 14.
3
Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.CDKN2A/B 缺失对急性淋巴细胞白血病预后意义的荟萃分析。
Ann Med. 2019 Feb;51(1):28-40. doi: 10.1080/07853890.2018.1564359. Epub 2019 Feb 14.
4
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.IKZF1 缺失是儿童 B 细胞前体急性淋巴细胞白血病的独立预后标志物，并可区分在维持治疗期间受益于脉冲治疗的患者：EORTC 儿童白血病组研究 58951 的结果。
Leukemia. 2015 Nov;29(11):2154-61. doi: 10.1038/leu.2015.134. Epub 2015 Jun 8.
5
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Ph 样急性淋巴细胞白血病中可靶向的激酶激活病变。
N Engl J Med. 2014 Sep 11;371(11):1005-15. doi: 10.1056/NEJMoa1403088.
6
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.核型是成人急性淋巴细胞白血病（ALL）的一个独立预后因素：对英国医学研究委员会（MRC）UKALLXII/东部肿瘤协作组（ECOG）2993试验中患者的细胞遗传学数据进行分析。
Blood. 2007 Apr 15;109(8):3189-97. doi: 10.1182/blood-2006-10-051912. Epub 2006 Dec 14.